Structural and functional biology of aldo-keto reductase steroid transforming enzymes

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586

Abiraterone and Increased Survival in Metastatic Prostate Cancer

de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407

Advanced Organic Chemistry: Reactions, Mechanisms, and Structure

March, J. (1977) · Andalas University Repository (Andalas University) · Cited by 4,022

Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628

Short-chain dehydrogenases/reductases (SDR)

Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzàlez‐Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,241

Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082

Medium- and short-chain dehydrogenase/reductase gene and protein families: The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes

Kavanagh, K. L., Jörnvall, H., Persson, B., & Oppermann, U. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8588-y · Cited by 908

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903

Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease

Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837

Intracrinology

Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685

Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649

Comparative anatomy of the aldo–keto reductase superfamily

Jez, J. M., BENNETT, M. J., Schlegel, B. P., Lewis, M., & Penning, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 603

The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification

Barski, O. A., Tipparaju, S. M., & Bhatnagar, A. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530802431439 · Cited by 560

Short‐chain dehydrogenases/reductases (SDRs)

Kallberg, Y., Oppermann, U. C. T., Jörnvall, H., & Persson, B. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03130.x · Cited by 437

An Unlikely Sugar Substrate Site in the 1.65 Å Structure of the Human Aldose Reductase Holoenzyme Implicated in Diabetic Complications

Wilson, D. K., Bohren, K. M., Gabbay, K. H., & Quiocho, F. A. (1992) · Science · doi:10.1126/science.1621098 · Cited by 434

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Danila, D. C., Morris, M. J., de Bono, J. S., Ryan, C. J., Denmeade, S. R., Smith, M. R., Taplin, M.-E., Bubley, G. J., Kheoh, T., Haqq, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9259 · Cited by 410

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8088 · Cited by 405

The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative

Persson, B., Kallberg, Y., Bray, J. E., Bruford, E. A., Dellaporta, S. L., Favia, A. D., Duarte, R. G., Jörnvall, H., Kavanagh, K. L., Kedishvili, N. Y., et al. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.040 · Cited by 397

Aldo-Keto Reductases and Bioactivation/Detoxication

Jin, Y., & Penning, T. M. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 391

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387

11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action

Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375

Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha- pregnan-20-one

Wang, M., Seippel, L., Purdy, R. H., & Bäckström, T. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772579 · Cited by 353

A new nomenclature for the aldo-keto reductase superfamily

Jez, J. M., Flynn, T. G., & Penning, T. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)84253-0 · Cited by 350

The backdoor pathway to dihydrotestosterone

Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

Chang, K.-H., Li, R., Papari-Zareei, M., Watumull, L., Zhao, Y. D., Auchus, R. J., & Sharifi, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107898108 · Cited by 346

Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one

Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 318

The aldo-keto reductase superfamily homepage

Hyndman, D., Bauman, D. R., Heredia, V. V., & Penning, T. M. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00193-x · Cited by 317

Intracrinology: Role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

Labrie, F., Luu-The, V, Lin, S., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., & Belanger, A. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250001 · Cited by 278

Human aldo–keto reductases: Function, gene regulation, and single nucleotide polymorphisms

Penning, T. M., & Drury, J. E. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.04.024 · Cited by 270

Human Cytosolic 3α-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3β-Hydroxysteroid Dehydrogenase Activity

Steckelbroeck, S., Jin, Y., Gopishetty, S., Oyesanmi, B., & Penning, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313308200 · Cited by 270

11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome

O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267

Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles

Agyeman, A. S., Chaerkady, R., Shaw, P. G., Davidson, N. E., Visvanathan, K., Pandey, A., & Kensler, T. W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1536-9 · Cited by 256

Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1

Dufort, I., Rheault, P., Huang, X.-F., Soucy, P., & Luu-The, V. (1999) · Endocrinology · doi:10.1210/endo.140.2.6531 · Cited by 255

Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.

Setchell, K. D. R., Suchy, F. J., Welsh, M. B., Zimmer-Nechemias, L., Heubi, J. E., & Balistreri, W. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113837 · Cited by 254

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Liu, C., Lou, W., Zhu, Y., Yang, J. C., Nadiminty, N., Gaikwad, N. W., Evans, C. P., & Gao, A. C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3080 · Cited by 248

Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation

Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248

Adrenal-Derived 11-Oxygenated 19-Carbon Steroids are the Dominant Androgens in Classic 21-Hydroxylase Deficiency

Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231

Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation

Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227

Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate

Biswas, M. G., & Russell, D. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15959 · Cited by 224

Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism

Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217

AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome

O’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215

Integrated view on 17beta-hydroxysteroid dehydrogenases

Moeller, G., & Adamski, J. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.040 · Cited by 214

Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors

Mitsiades, N., Sung, C. C., Schultz, N. D., Danila, D. C., He, B., Eedunuri, V. K., Fleisher, M., Sander, C., Sawyers, C. L., & Scher, H. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1335 · Cited by 203

Expression and Characterization of Recombinant Type 2 3α-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3α/17β-HSD Activity and Cellular Distribution

Lin, H.-K., Jez, J. M., Schlegel, B. P., Peehl, D. M., Pachter, J. A., & Penning, T. M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.13.0026 · Cited by 194

Structure and function of human 17β-hydroxysteroid dehydrogenases

Lukacik, P., Kavanagh, K. L., & Oppermann, U. C. T. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.007 · Cited by 192

The Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto Reductase AKR1C1 Reduces the α,β-Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 1,4-Dihydroxy-2-nonene

Burczynski, M. E., Gopishetty, S. R., Palackal, N. T., & Penning, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006655200 · Cited by 191

Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.

Burczynski, M. E., Hseuh-Kung, L. I. N., & Penning, T. M. (1999) · PubMed · Cited by 189

Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer

Hofland, J., van Weerden, W. M., Dits, N. F. J., Steenbergen, J., van Leenders, G. J. L. H., Jenster, G., Schröder, F. H., & de Jong, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2092 · Cited by 176

Substrate specificity, gene structure and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases

Khanna, M., Qin, K.-N., Wang, R. W., & Cheng, K.-C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20162 · Cited by 174

5α-Androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate

Wilson, J. D., Auchus, R. J., Leihy, M. W., Guryev, O. L., Estabrook, R. W., Osborn, S. M., Shaw, G., & Renfree, M. B. (2003) · Endocrinology · doi:10.1210/en.2002-220721 · Cited by 172

Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

Allegra, J. C., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Green, L., Kk, H., Do, H. M., & Aitken, S. C. (1979) · PubMed · Cited by 162

AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer

Rižner, T. L., Šmuc, T., Rupreht, R., Šinkovec, J., & Penning, T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.009 · Cited by 159

Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.

Wood, S. H., Mortola, J. F., Chan, Y., Moossazadeh, F., & Yen, S. S. C. (1992) · PubMed · Cited by 155

A MAMMALIAN 3α-HYDROXYSTEROID DEHYDROGENASE

Tomkins, G. M. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65907-1 · Cited by 150

An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies

Byrns, M. C., Steckelbroeck, S., & Penning, T. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.008 · Cited by 145

Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights

Byrns, M. C., Jin, Y., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.004 · Cited by 145

A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids

Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142

Cloning and expression of cDNA of human Δ4‐3‐oxosteroid 5β‐reductase and substrate specificity of the expressed enzyme

KONDO, K., KAI, M., SETOGUCHI, Y., EGGERTSEN, G., SJÖBLOM, P., SETOGUCHI, T., OKUDA, K., & BJÖRKHEM, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19947.x · Cited by 139

Mutagenesis of 3α-Hydroxysteroid Dehydrogenase Reveals a “Push−Pull” Mechanism for Proton Transfer in Aldo−Keto Reductases

Schlegel, B. P., Jez, J. M., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi9723055 · Cited by 139

The Androgen Derivative 5α-Androstane-3β,17β-Diol Inhibits Prostate Cancer Cell Migration Through Activation of the Estrogen Receptor β Subtype

Guerini, V., Sau, D., Scaccianoce, E., Rusmini, P., Ciana, P., Maggi, A. C., Martini, P. G. V., Katzenellenbogen, B. S., Martini, L., Motta, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1941 · Cited by 138

Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action

Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 137

Human type 3 3α-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells

Rižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M. (2003) · Endocrinology · doi:10.1210/en.2002-0032 · Cited by 132

cDNA cloning, expression and characterization of human prostaglandin F synthase1

Suzuki-Yamamoto, T., Nishizawa, M., Fukui, M., Okuda‐Ashitaka, E., Nakajima, T., Ito, S., & Watanabe, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01551-3 · Cited by 131

Type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis

Nakamura, Y., Hornsby, P. J., Casson, P., Morimoto, R., Satoh, F., Xing, Y., Kennedy, M. R., Sasano, H., & Rainey, W. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2374 · Cited by 129

Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma

Fung, K.-M., Samara, E. N. S., Wong, C., Metwalli, A., Krlin, R., Bane, B., Liu, C. Z., Yang, J. T., Pitha, J. V., Culkin, D. J., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01048 · Cited by 129

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor

Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00846 · Cited by 129

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma

Lewis, M. J., Wiebe, J. P., & Heathcote, J. G. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-27 · Cited by 127

Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer

Liu, C., Armstrong, C. M., Lou, W., Lombard, A. P., Evans, C. P., & Gao, A. C. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0186 · Cited by 126

Mutations in SRD5B1 ( AKR1D1 ), the gene encoding Δ 4 -3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy

Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scambler, P. J., & Clayton, P. T. (2003) · Gut · doi:10.1136/gut.52.10.1494 · Cited by 125

Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth

Yepuru, M., Wu, Z., Kulkarni, A. L., Yin, F., Barrett, C. M., Kim, J.-H., Steiner, M. S., Miller, D. D., Dalton, J. T., & Narayanan, R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1151 · Cited by 122

Identification of the Major Oxidative 3α-Hydroxysteroid Dehydrogenase in Human Prostate That Converts 5α-Androstane-3α,17β-diol to 5α-Dihydrotestosterone: A Potential Therapeutic Target for Androgen-Dependent Disease

Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., & Penning, T. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0287 · Cited by 120

Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling

Ji, Q., Aoyama, C., Nien, Y.-D., Liu, P. I., Chen, P. K., Chang, L., Stanczyk, F. Z., & Stolz, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1608 · Cited by 119

Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase

Bennett, M. J., Albert, R. H., Jez, J. M., Ma, H., Penning, T. M., & Lewis, M. (1997) · Structure · doi:10.1016/s0969-2126(97)00234-7 · Cited by 117

Aldo–keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer

Byrns, M. C., Duan, L., Lee, S. H., Blair, I. A., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.009 · Cited by 116

Long-term adjuvant tamoxifen therapy for breast cancer

Jordan, V. C. (1990) · Breast Cancer Research and Treatment · doi:10.1007/bf01806350 · Cited by 116

3α-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period

Evans, S. E. G., Ross, L. E., Sellers, E. M., Purdy, R. H., & Romach, M. K. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500361747 · Cited by 114

Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N -Phenyl-Aminobenzoates and Their Structure–Activity Relationships

Adeniji, A. O., Twenter, B. M., Byrns, M. C., Jin, Y., Chen, M., Winkler, J. D., & Penning, T. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201547v · Cited by 113

Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells

Hara, A., Matsuura, K., Tamada, Y., Sato, K., Miyabe, Y., Deyashiki, Y., & ISHIDA, N. (1996) · Biochemical Journal · doi:10.1042/bj3130373 · Cited by 109

Characterization of a human 20alpha-hydroxysteroid dehydrogenase

Zhang, Y., Dufort, I., Rheault, P., & Luu-The, V. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250221 · Cited by 109

cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family

Stolz, A., Hammond, L. E., Lou, H., Takikawa, H., Ronk, M., & Shively, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82220-7 · Cited by 108

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

Liedtke, A. J., Adeniji, A. O., Chen, M., Byrns, M. C., Jin, Y., Christianson, D. W., Marnett, L. J., & Penning, T. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017656 · Cited by 108

Stimulation of hemoglobin synthesis in chick blastoderms by certain 5beta androstane and 5beta pregnane steroids.

Levere, R. D., Kappas, A., & Granick, S. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.3.985 · Cited by 108

11-Oxygenated Androgens are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency

Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3989 · Cited by 107

Studies on pig muscle aldose reductase. Kinetic mechanism and evidence for a slow conformational change upon coenzyme binding.

Kubiseski, T. J., Hyndman, D., Morjana, N. A., & Flynn, T. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50457-4 · Cited by 105

Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor

Whorwood, C. B., Franklyn, J. A., Sheppard, M. C., & Stewart, P. M. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90220-d · Cited by 103

Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol

Shaw, G., Renfree, M. B., Leihy, M. W., Shackleton, C. H. L., Roitman, E., & Wilson, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220412297 · Cited by 101

THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX

Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Worldwide Protein Data Bank · doi:10.2210/pdb1abn/pdb · Cited by 99

Crystal Structure of Human Type III 3α-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein Complexed with NADP+ and Ursodeoxycholate,

Jin, Y., Stayrook, S. E., Albert, R. H., Palackal, N. T., Penning, T. M., & Lewis, M. (2001) · Biochemistry · doi:10.1021/bi010919a · Cited by 99

Partial reduction of steroid hormones and related substances

Norymberski, J. K., & Woods, G. F. (1955) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9550003426 · Cited by 96

Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review

Penning, T. M. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1379503 · Cited by 96

Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

Penning, T. M., Burczynski, M. E., Jez, J. M., Lin, H.-K., Ma, H., Moore, M., Ratnam, K., & Palackal, N. T. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00426-3 · Cited by 95

Human Aldose Reductase: Rate Constants for a Mechanism Including Interconversion of Ternary Complexes by Recombinant Wild-Type Enzyme

Grimshaw, C. E., Bohren, K. M., Lai, C.-J., & Gabbay, K. H. (1995) · Biochemistry · doi:10.1021/bi00044a012 · Cited by 95

Structure of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase Complexed with NADP+

Bennett, M. J., Schlegel, B. P., Jez, J. M., Penning, T. M., & Lewis, M. (1996) · Biochemistry · doi:10.1021/bi9604688 · Cited by 92

The crystal structure of the aldose reductase.NADPH binary complex.

Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35840-x · Cited by 92

Aldo-keto Reductase Family 1 Member C3 (AKR1C3) Is a Biomarker and Therapeutic Target for Castration-Resistant Prostate Cancer

Hamid, A. R. A. H., Pfeiffer, M. J., Verhaegh, G. W. C. T., Schaafsma, E., Brandt, A. M., Sweep, F. C. G. J., Sedelaar, J. P. M., & Schalken, J. A. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00296 · Cited by 87

Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism

Ji, Q., Chang, L., Vandenberg, D. J., Stanczyk, F. Z., & Stolz, A. (2003) · The Prostate · doi:10.1002/pros.10192 · Cited by 86

Steroid Modulation of the GABA A Receptor Complex: Electrophysiological Studies

Lambert, J. J., Peters, J. A., Sturgess, N. C., & Hales, T. G. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513989.ch4 · Cited by 84

Kinetics of Allopregnanolone Formation Catalyzed by Human 3α-Hydroxysteroid Dehydrogenase Type III (AKR1C2)

Trauger, J. W., Jiang, A., Stearns, B. A., & LoGrasso, P. V. (2002) · Biochemistry · doi:10.1021/bi026109w · Cited by 81

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Veliça, P., Davies, N., Rocha, P. P., Schrewe, H., Ride, J. P., & Bunce, C. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-121 · Cited by 80

Crystal Structure of Human Liver Δ4-3-Ketosteroid 5β-Reductase (AKR1D1) and Implications for Substrate Binding and Catalysis

Di Costanzo, L., Drury, J. E., Penning, T. M., & Christianson, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801778200 · Cited by 79

Human 20α–Hydroxysteroid Dehydrogenase: Crystallographic and Site-directed Mutagenesis Studies Lead to the Identification of an Alternative Binding Site for C21-steroids

Couture, J., Legrand, P., Cantin, L., Luu-The, V., Labrie, F., & Breton, R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00762-9 · Cited by 77

Crystal Structures of the Multispecific 17β-Hydroxysteroid Dehydrogenase Type 5: Critical Androgen Regulation in Human Peripheral Tissues

Qiu, W., Zhou, M., Labrie, F., & Lin, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0032 · Cited by 76

Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.

Clayton, P. T., Mills, K. A., Johnson, A. W., Barabino, A. V., & Marazzi, M. G. (1996) · Gut · doi:10.1136/gut.38.4.623 · Cited by 75

Conversion of Cholesterol to Bile Acids in Rat: Purification and Properties of a Δ4‐3‐Ketosteroid 5β‐Reductase and a 3α‐Hydroxysteroid Dehydrogenase

Berséus, O. (1967) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1967.tb00163.x · Cited by 74

Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1

Dufort, I., Labrie, F., & Luu-The, V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7216 · Cited by 73

17β-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor–Positive Breast Cancer

Jansson, A., Gunnarsson, C., Cohen, M., Sivik, T., & Stål, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1448 · Cited by 73

Transcript Profiling of the Androgen Signal in Normal Prostate, Benign Prostatic Hyperplasia, and Prostate Cancer

Bauman, D. R., Steckelbroeck, S., Peehl, D. M., & Penning, T. M. (2006) · Endocrinology · doi:10.1210/en.2006-0627 · Cited by 72

ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells

Powell, K., Semaan, L., Conley‐LaComb, M. K., Asangani, I. A., Wu, Y.-M., Ginsburg, K., Williams, J. L., Squire, J. A., Maddipati, K. R., Cher, M. L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2352 · Cited by 70

Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling

Ji, Q., Chang, L., Stanczyk, F. Z., Ookhtens, M., Sherrod, A. E., & Stolz, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1593 · Cited by 69

SRD5B1 (AKR1D1) gene analysis in Δ4-3-oxosteroid 5β-reductase deficiency: evidence for primary genetic defect

Gonzales, E., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M.-F., & Jacquemin, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.024 · Cited by 68

The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3α-hydroxysteroid dehydrogenase, a representative aldo-keto reductase

Ratnam, K., Ma, H., & Penning, T. M. (1999) · Biochemistry · doi:10.1021/bi982838t · Cited by 68

Purification and characterization of delta 4-3-ketosteroid 5 beta-reductase.

Okuda, A., & Okuda, K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42821-3 · Cited by 67

Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study

Loriot, Y., Fizazi, K. S., Jones, R. J., den Brande, J. V., Molife, R., Omlin, A. G., James, N. D., Baskin-Bey, E. S., Heeringa, M. J., Baron, B., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0101-x · Cited by 65

Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer

Chen, M., Adeniji, A. O., Twenter, B. M., Winkler, J. D., Christianson, D. W., & Penning, T. M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.085 · Cited by 65

Engineering Steroid 5β-Reductase Activity into Rat Liver 3α-Hydroxysteroid Dehydrogenase

Jez, J. M., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi980294p · Cited by 63

In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)

Kikuchi, A., Furutani, T., Azami, H., Watanabe, K., Niimi, T., Kamiyama, Y., Kuromitsu, S., Baskin-Bey, E. S., Heeringa, M. J., Ouatas, T., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0130-5 · Cited by 63

Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome

O’Reilly, M., Gathercole, L., Capper, F., Arlt, W., & Tomlinson, J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60331-2 · Cited by 62

Multiple steps determine the overall rate of the reduction of 5α-dihydrotestosterone catalyzed by human type 3 3α-hydroxysteroid dehydrogenase: implications for the elimination of androgens

Jin, Y., & Penning, T. M. (2006) · Biochemistry · doi:10.1021/bi060591r · Cited by 60

Overexpression of aldo–keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride

Byrns, M. C., Mindnich, R., Duan, L., & Penning, T. M. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.012 · Cited by 60

Pre-receptor regulation of the androgen receptor

Penning, T. M., Jin, Y., Rižner, T. L., & Bauman, D. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.10.008 · Cited by 60

Elucidation of a Complete Kinetic Mechanism for a Mammalian Hydroxysteroid Dehydrogenase (HSD) and Identification of All Enzyme Forms on the Reaction Coordinate

Cooper, W. C., Jin, Y., & Penning, T. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703414200 · Cited by 58

Positional conservation and amino acids shape the correct diagnosis and population frequencies of benign and damaging personal amino acid mutationsPreprint

Kumar, S., Suleski, M., Markov, G. J., Lawrence, S., Marco, A. D., & Filipski, A. J. (2009) · Genome Research · doi:10.1101/gr.091991.109 · Cited by 58

Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues

Sharma, K. K., Lindqvist, A., Zhou, X. J., Auchus, R. J., Penning, T. M., & Andersson, S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.024 · Cited by 57

Aromatase inhibitors in breast cancer

Brodie, A. M. H. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00529-x · Cited by 56

AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

Tian, Y., Zhao, L., Zhang, H., Liu, X., Zhao, L., Zhao, X., Li, Y., & Li, J. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-42 · Cited by 54

Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)

Chen, M., Drury, J. E., & Penning, T. M. (2011) · Steroids · doi:10.1016/j.steroids.2011.01.003 · Cited by 53

Human Aldose Reductase: pK of Tyrosine 48 Reveals the Preferred Ionization State for Catalysis and Inhibition

Grimshaw, C. E., Bohren, K. M., Lai, C.-J., & Gabbay, K. H. (1995) · Biochemistry · doi:10.1021/bi00044a014 · Cited by 52

5β-Dihydroprogesterone and steroid 5β-reductase decrease in association with human parturition at term

Sheehan, P. M., Rice, G. E., Moses, E. K., & Brennecke, S. P. (2005) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gah201 · Cited by 52

Conversion of mammalian 3α-hydroxysteroid dehydrogenase to 20α-hydroxysteroid dehydrogenase using loop chimeras: Changing specificity from androgens to progestins

Ma, H., & Penning, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11161 · Cited by 52

5α-pregnan-3α,20α-diol behaves like a partial agonist in the modulation of GABA-stimulated chlride ion uptake by synaptoneurosomes

Belelli, D., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90760-7 · Cited by 51

Characterization of disease-related 5β-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency

Drury, J. E., Mindnich, R., & Penning, T. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127779 · Cited by 51

Identification of the molecular switch that regulates access of 5α-DHT to the androgen receptor

Penning, T. M., Bauman, D. R., Jin, Y., & Rižner, T. L. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.007 · Cited by 50

Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo–keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway

Jin, Y., Mesaros, A. C., Blair, I. A., & Penning, T. M. (2011) · Biochemical Journal · doi:10.1042/bj20101804 · Cited by 49

Aldo–keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis

Hevir, N., Vouk, K., Šinkovec, J., Ribič-Pucelj, M., & Lanišnik Rižner, T. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.003 · Cited by 48

Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer

Fankhauser, M., Tan, Y., Macintyre, G., Haviv, I., Hong, M. K. H., Nguyen, A., Pedersen, J. S., Costello, A. J., Hovens, C. M., & Corcoran, N. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3483 · Cited by 48

Molecular cloning and sequence analysis of cDNA encoding δ4‐3‐ketosteroid 5β‐reductase of rat liver

Onishi, Y., Noshiro, M., SHIMOSATO, T., & Okuda, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80591-p · Cited by 45

Discovery of (R)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor

Adeniji, A. O., Uddin, M. J., Zang, T., Tamae, D., Wangtrakuldee, P., Marnett, L. J., & Penning, T. M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00160 · Cited by 45

In situ production of sex steroids in human breast carcinoma

Suzuki, T., Miki, Y., Moriya, T., Akahira, J., Hirakawa, H., Ohuchi, N., & Sasano, H. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0365-8 · Cited by 43

Progesterone metabolite and spontaneous myometrial contractions in vitro

Thornton, S., Terzidou, V., Clark, A., & Blanks, A. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05247-7 · Cited by 42

Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis

Matsuura, K., Deyashiki, Y., Sato, K., ISHIDA, N., Miwa, G., & Hara, A. (1997) · Biochemical Journal · doi:10.1042/bj3230061 · Cited by 42

Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines

Sinreih, M., Anko, M., Zukunft, S., Adamski, J., & Rižner, T. L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.11.012 · Cited by 41

SRD5B1 gene analysis needed for the accurate diagnosis of primary 3‐oxo‐Δ4‐steroid 5β‐reductase deficiency

Ueki, I., Kimura, A., Chen, H., Yorifuji, T., Mori, J., Itoh, S., Maruyama, K., Ishige, T., Takei, H., Nittono, H., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05669.x · Cited by 41

Age-dependent increases in adrenal cytochrome b5 and serum 5-androstenediol-3-sulfate

Rege, J., Karashima, S., Lerario, A. M., Smith, J. M., Auchus, R. J., Kasa-Vubu, J. Z., Sasano, H., Nakamura, Y., White, P. C., & Rainey, W. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2864 · Cited by 40

Structure and catalytic mechanism of human steroid 5β-reductase (AKR1D1)

Costanzo, L. D., Drury, J. E., Christianson, D. W., & Penning, T. M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.013 · Cited by 39

Gene analysis in δ-3-oxosteroid 5β–reductase deficiency

Sumazaki, R., Nakamura, N., Shoda, J., Kurosawa, T., & Tohma, M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62828-0 · Cited by 37

Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences

Jin, Y., & Penning, T. M. (2006) · Steroids · doi:10.1016/j.steroids.2005.12.002 · Cited by 37

The influence of steroid hormone metabolites on the in vitro development of erythroid colonies derived from human bone marrow.

Urabe, A., Sassa, S., & Kappas, A. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.149.6.1314 · Cited by 36

Aldo-keto Reductase 1B15 (AKR1B15)

Weber, S., Salabei, J. K., Möller, G., Kremmer, E., Bhatnagar, A., Adamski, J., & Barski, O. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610121 · Cited by 35

Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure–activity relationships

Bhatia, C., Oerum, S., Bray, J. E., Kavanagh, K. L., Shafqat, N., Yue, W. W., & Oppermann, U. C. T. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.013 · Cited by 35

Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases

Platt, A., Xia, Z., Liu, Y., Chen, G., & Lazarus, P. J. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000226 · Cited by 31

Functional expression of novel human and murine AKR1B genes

Salabei, J. K., Li, X., Petrash, J. M., Bhatnagar, A., & Barski, O. A. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.020 · Cited by 30

Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population

Ju, R., Wu, W., Fei, J., Qin, Y., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0615 · Cited by 27

Genome-Wide Analysis of Human Disease Alleles Reveals That Their Locations Are Correlated in Paralogous Proteins

Yandell, M. D., Moore, B., Salas, F., Mungall, C., MacBride, A. R., White, C., & Reese, M. G. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000218 · Cited by 25

Arginine 276 controls the directional preference of AKR1C9 (rat liver 3α-hydroxysteroid dehydrogenase) in human embryonic kidney 293 cells

Papari-Zareei, M., Brandmaier, A., & Auchus, R. J. (2006) · Endocrinology · doi:10.1210/en.2005-1141 · Cited by 23

Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors

El-Kabbani, O. A. L., Scammells, P. J., Day, T., Dhagat, U., Endo, S., Matsunaga, T., Soda, M., & Hara, A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.052 · Cited by 21

The Effect of Allelic Variation in Aldo-Keto Reductase 1C2 on the in Vitro Metabolism of Dihydrotestosterone

Takahashi, R. H., Grigliatti, T. A., Reid, R. E., & Riggs, K. W. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.150995 · Cited by 21

P0188 SRD5B1 (AKR1D1) GENE ANALYSIS IN DELTA4???3-OXOSTEROID 5BETA-REDUCTASE DEFICIENCY: EVIDENCE FOR PRIMARY GENETIC DEFECT

Gonzales, E. M., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M., & Jacquemin, E. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200406001-00312 · Cited by 20

Alanine Scanning Mutagenesis of the Testosterone Binding Site of Rat 3α-Hydroxysteroid Dehydrogenase Demonstrates Contact Residues Influence the Rate-Determining Step

Heredia, V. V., Cooper, W. C., Kruger, R. G., Jin, Y., & Penning, T. M. (2004) · Biochemistry · doi:10.1021/bi0499563 · Cited by 19

Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): The V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity

Zhang, B., Zhu, D., Hu, X., Zhou, M., Shang, P., & Lin, S. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.003 · Cited by 16

The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function

Mindnich, R., Drury, J. E., & Penning, T. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.12.020 · Cited by 16

Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis

El-Kabbani, O. A. L., Dhagat, U., Soda, M., Endo, S., Matsunaga, T., & Hara, A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.076 · Cited by 12

In-Depth Dissection of the P133R Mutation in Steroid 5β-Reductase (AKR1D1): A Molecular Basis of Bile Acid Deficiency

Chen, M., Jin, Y., & Penning, T. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00816 · Cited by 12

Kinetic alteration of a human dihydrodiol/3α-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine

Tatuya, O. H. T. A., Ishikura, S., Shintani, S., Usami, N., & Hara, A. (2000) · Biochemical Journal · doi:10.1042/bj3520685 · Cited by 9

Functional Significance May Underlie the Taxonomic Utility of Single Amino Acid Substitutions in Conserved Proteins

Tyler, K. M., Wagner, G. K., Wu, Q., & Huber, K. T. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9338-y · Cited by 8

A Single Nucleotide Variant in the Promoter Region of 17β-HSD Type 5 Gene Influences External Genitalia Virilization in Females with 21-Hydroxylase Deficiency

Kaupert, L. C., Gomes, L. G., Brito, V. N., de Lemos‐Marini, S. H. V., de Mello, M. P., Longui, C. A., Kochi, C., de Castro, M., Guerra‐Júnior, G., Mendonca, B. B., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000445684 · Cited by 7

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review

Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450

11-Oxygenated androgens in health and disease

Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217

The Biosynthesis of Enzymatically Oxidized Lipids

Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 198

Aldo-Keto Reductases and Cancer Drug Resistance

Penning, T. M., Jonnalagadda, S. K., Trippier, P. C., & Rižner, T. L. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000122 · Cited by 158

Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega

Doden, H. L., & Ridlon, J. M. (2021) · Microorganisms · doi:10.3390/microorganisms9030469 · Cited by 113

Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism

Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217

The roles of aldo-keto reductases in steroid hormone action

Bauman, D. R., Steckelbroeck, S., & Penning, T. M. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.9.872570 · Cited by 71

Promiscuity and diversity in 3-ketosteroid reductases

Penning, T. M., Chen, M., & Jin, Y. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.12.003 · Cited by 36

Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4

Brožič, P., Turk, S., Rižner, T. L., & Gobec, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933713 · Cited by 44

Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)

Chen, M., Drury, J. E., & Penning, T. M. (2011) · Steroids · doi:10.1016/j.steroids.2011.01.003 · Cited by 53